The overall goal of this Program Project Grant (PPG) application is to advance the basic understanding of a major endoplasmic reticulum chaperone, grp94, with the ultimate objective of defining and testing rational grp94-based therapeutics for cancer. To accomplish this goal, scientists with noted expertise in grp94 research from three research institutions ? Medical University of South Carolina, Memorial Sloan-Kettering Cancer Center and Hauptman-Woodward Medical Research Institute ? have come together to propose three integrated research projects. The Administration & Biostatistics Core (Core 1) is mission-critical to the overall management of this PPG, given the potential geographic challenges and complex interactions among the three projects and the Medicinal Chemistry Core. Core 1 will oversee and manage the progression of research milestones across the projects and significantly enhance the sharing, evaluation and integration of new knowledge into a common research direction for this assembled team of investigators. To fulfill these responsibilities, the core has six specific aims:
Aim 1. Organize monthly webcam-based conferences for the Project and Core Leaders and team members, and more frequent meetings as needed Aim 2. Create and maintain a PPG website and secure portal for enhanced communications and data dissemination by the individual projects.
Aim 3. Facilitate constructive review and enhancement of the research progress through meticulously planned and organized interactions with expert Internal and External Scientific Advisory Committees.
Aim 4. Organize and coordinate annual retreats and symposia on grp94 chaperone biology in cancer in Charleston, SC.
Aim 5. Deliver general administrative and fiscal management support to ensure effective and efficient inter-institutional communication, coordination and compliance with all terms and conditions of the grant.
Aim 6. Provide centralized expert biostatistical consultation and services to the research projects and Medicinal Chemistry Core.

Public Health Relevance

This multi-project initiative brings together cancer biologists, structural biologists and medicinal chemists/chemical biologists to advance the basic understanding of a major cell stress molecule known as grp94 in order to define and test the rational development of new therapies for cancer. The Administration & Biostatistics Core is essential to this effort as it serves as the catalyst for bringing synergy to all the projects in addition to providing integrated leadership, scientific oversight, centralized biostatistical services, and administrative and fiscal support to this multi-institutional program project initiative.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA186866-03
Application #
9321012
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2017-09-01
Budget End
2018-08-31
Support Year
3
Fiscal Year
2017
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29403
Metelli, Alessandra; Salem, Mohammad; Wallace, Caroline H et al. (2018) Immunoregulatory functions and the therapeutic implications of GARP-TGF-? in inflammation and cancer. J Hematol Oncol 11:24
Kaittanis, Charalambos; Andreou, Chrysafis; Hieronymus, Haley et al. (2018) Prostate-specific membrane antigen cleavage of vitamin B9 stimulates oncogenic signaling through metabotropic glutamate receptors. J Exp Med 215:159-175
Lin, Ching Ying; Kwon, Hyunwoo; Rangel Rivera, Guillermo O et al. (2018) Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma. Cancer Epidemiol Biomarkers Prev 27:1176-1185
Que, Nanette L S; Crowley, Vincent M; Duerfeldt, Adam S et al. (2018) Structure Based Design of a Grp94-Selective Inhibitor: Exploiting a Key Residue in Grp94 To Optimize Paralog-Selective Binding. J Med Chem 61:2793-2805
Speranza, Giovanna; Anderson, Larry; Chen, Alice P et al. (2018) First-in-human study of the epichaperome inhibitor PU-H71: clinical results and metabolic profile. Invest New Drugs 36:230-239
Joshi, Suhasini; Wang, Tai; Araujo, ThaĆ­s L S et al. (2018) Adapting to stress - chaperome networks in cancer. Nat Rev Cancer 18:562-575
Kishinevsky, Sarah; Wang, Tai; Rodina, Anna et al. (2018) HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons. Nat Commun 9:4345
Zhang, Jingyu; Liu, Dai; Li, Guangfu et al. (2017) Antibody-mediated neutralization of soluble MIC significantly enhances CTLA4 blockade therapy. Sci Adv 3:e1602133
Neitzke, Daniel J; Bowers, Jacob S; Andrijauskaite, Kristina et al. (2017) Murine Th17 cells utilize IL-2 receptor gamma chain cytokines but are resistant to cytokine withdrawal-induced apoptosis. Cancer Immunol Immunother 66:737-751
Rachidi, Saleh; Metelli, Alessandra; Riesenberg, Brian et al. (2017) Platelets subvert T cell immunity against cancer via GARP-TGF? axis. Sci Immunol 2:

Showing the most recent 10 out of 55 publications